Correlation Between Treasury Wine and Apogee Therapeutics,

Can any of the company-specific risk be diversified away by investing in both Treasury Wine and Apogee Therapeutics, at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Treasury Wine and Apogee Therapeutics, into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Treasury Wine Estates and Apogee Therapeutics, Common, you can compare the effects of market volatilities on Treasury Wine and Apogee Therapeutics, and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Treasury Wine with a short position of Apogee Therapeutics,. Check out your portfolio center. Please also check ongoing floating volatility patterns of Treasury Wine and Apogee Therapeutics,.

Diversification Opportunities for Treasury Wine and Apogee Therapeutics,

0.75

Correlation Coefficient

Treasury Wine  Apogee Therapeutics,

Poor diversification

The 3 months correlation between Treasury and Apogee is 0.75. Overlapping area represents the amount of risk that can be diversified away by holding Treasury Wine Estates and Apogee Therapeutics, Common in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Apogee Therapeutics, and Treasury Wine is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Treasury Wine Estates are associated (or correlated) with Apogee Therapeutics,. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Apogee Therapeutics, has no effect on the direction of Treasury Wine i.e., Treasury Wine and Apogee Therapeutics, go up and down completely randomly.

Pair Corralation between Treasury Wine and Apogee Therapeutics,

Assuming the 90 days horizon Treasury Wine Estates is expected to under-perform the Apogee Therapeutics,. But the pink sheet apears to be less risky and, when comparing its historical volatility, Treasury Wine Estates is 3.12 times less risky than Apogee Therapeutics,. The pink sheet trades about -0.15 of its potential returns per unit of risk. The Apogee Therapeutics, Common is currently generating about 0.03 of returns per unit of risk over similar time horizon. If you would invest  4,907  in Apogee Therapeutics, Common on October 10, 2024 and sell it today you would earn a total of  50.00  from holding Apogee Therapeutics, Common or generate 1.02% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Significant
Accuracy	95.24%
Values	Daily Returns

Treasury Wine Estates  vs.  Apogee Therapeutics, Common

Treasury Wine Estates

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Treasury Wine Estates has generated negative risk-adjusted returns adding no value to investors with long positions. Despite latest weak performance, the Stock's basic indicators remain stable and the current disturbance on Wall Street may also be a sign of long-run gains for the company stockholders.

Apogee Therapeutics,

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Apogee Therapeutics, Common has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of rather sound technical and fundamental indicators, Apogee Therapeutics, is not utilizing all of its potentials. The latest stock price tumult, may contribute to shorter-term losses for the shareholders.

Pair Trading with Treasury Wine and Apogee Therapeutics,

The main advantage of trading using opposite Treasury Wine and Apogee Therapeutics, positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Treasury Wine position performs unexpectedly, Apogee Therapeutics, can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Apogee Therapeutics, will offset losses from the drop in Apogee Therapeutics,'s long position.

The idea behind Treasury Wine Estates and Apogee Therapeutics, Common pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio File Import module to quickly import all of your third-party portfolios from your local drive in csv format.